<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37364498</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5967</ISSN><JournalIssue CitedMedium="Internet"><Volume>165</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</Title><ISOAbbreviation>J Clin Virol</ISOAbbreviation></Journal><ArticleTitle>Laboratory assessment of a multi-target assay for the rapid detection of viruses causing vesicular diseases.</ArticleTitle><Pagination><StartPage>105525</StartPage><MedlinePgn>105525</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcv.2023.105525</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-6532(23)00148-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">The recent mpox outbreak has highlighted the need to rapidly diagnose the causative agents of viral vesicular disease to inform treatment and control measures. Common causes of vesicular disease include Monkeypox virus (MPXV), clades I and II, Herpes simplex viruses Type 1 and Type 2 (HSV-1, HSV-2), human herpes virus 6 (HHV-6), Varicella-zoster virus (VZV) and Enteroviruses (EVs). Here, we assessed a syndromic viral vesicular panel for rapid and simultaneous detection of these 7 targets in a single cartridge.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to evaluate the QIAStat-Dx ® viral vesicular (VV) panel and compare with laboratory developed tests (LDTs). Limit of detection, inter-run variability, cross-reactivity and specificity were assessed. Positive and negative percent agreement, and correlation between assays was determined using 124 clinical samples from multiple anatomical sites.</AbstractText><AbstractText Label="RESULTS">The overall concordance between the QIAstat and LDTs was 96%. Positive percent agreement was 82% for HHV-6, 89% for HSV-1 and 100% for MPXV, HSV-2, EV and VZV. Negative percent agreement was 100% for all targets assessed. There was no cross-reactivity with Vaccinia, Orf, Molluscum contagiosum viruses, and a pooled respiratory panel.</AbstractText><AbstractText Label="CONCLUSION">The QIAstat VV multi-target syndromic panel combine ease of use, rapid turnaround, good sensitivity and specificity for enhanced diagnosis, clinical care and public health responses.</AbstractText><CopyrightInformation>Copyright © 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batty</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadakis</LastName><ForeName>Georgina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Changxu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Druce</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Chuan Kok</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Deborah A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia. Electronic address: kathy.jackson@mh.org.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Virol</MedlineTA><NlmUniqueID>9815671</NlmUniqueID><ISSNLinking>1386-6532</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006561" MajorTopicYN="N">Herpes Simplex</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018259" MajorTopicYN="N">Herpesvirus 1, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018258" MajorTopicYN="N">Herpesvirus 2, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014645" MajorTopicYN="N">Herpesvirus 3, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015654" MajorTopicYN="N">Herpesvirus 6, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008993" MajorTopicYN="N">Monkeypox virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Herpes simplex virus</Keyword><Keyword MajorTopicYN="N">Human herpes virus 6</Keyword><Keyword MajorTopicYN="N">Monkeypox virus</Keyword><Keyword MajorTopicYN="N">Varicella-zoster virus</Keyword><Keyword MajorTopicYN="N">Vesicular disease</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors do not have any conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37364498</ArticleId><ArticleId IdType="pmc">PMC10287189</ArticleId><ArticleId IdType="doi">10.1016/j.jcv.2023.105525</ArticleId><ArticleId IdType="pii">S1386-6532(23)00148-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prevention CfDCa. 2022 Mpox outbreak global map. 2023.</Citation></Reference><Reference><Citation>Ahmed M., Naseer H., Arshad M., Ahmad A. Monkeypox in 2022: a new threat in developing. Ann. Med. Surgery. 2022;78</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9207131</ArticleId><ArticleId IdType="pubmed">35734647</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornhill J.P., Barkati S., Walmsley S., Rockstroh J., Antinori A., Harrison L.B., et al. Monkeypox virus infection in humans across 16 Countries - April-June 2022. N. Engl. J. Med. 2022;387:679–691.</Citation><ArticleIdList><ArticleId IdType="pubmed">35866746</ArticleId></ArticleIdList></Reference><Reference><Citation>Shchelkunov S.N., Shcherbakov D.N., Maksyutov R.A., Gavrilova E.V. Species-specific identification of variola, monkeypox, cowpox, and vaccinia viruses by multiplex real-time PCR assay. J. Virol. Methods. 2011;175:163–169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9628778</ArticleId><ArticleId IdType="pubmed">21635922</ArticleId></ArticleIdList></Reference><Reference><Citation>Boers S.A., Melchers W.J.G., Peters C.J.A., Toonen M., McHugh M.P., Templeton K.E., et al. Multicenter evaluation of QIAstat-Dx respiratory panel V2 for detection of viral and bacterial respiratory pathogens. J. Clin. Microbiol. 2020;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269373</ArticleId><ArticleId IdType="pubmed">32229601</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansarli G.S., Chapin K.C. Diagnostic test accuracy of the BioFire(R) FilmArray(R) meningitis/encephalitis panel: a systematic review and meta-analysis. Clin. Microbiol. Infect. 2020;26:281–290.</Citation><ArticleIdList><ArticleId IdType="pubmed">31760115</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotosamimanana N., Randrianirina F., Randremanana R., Raherison M.S., Rasolofo V., Solofomalala G.D., et al. GeneXpert for the diagnosis of COVID-19 in LMICs. Lancet Glob. Health. 2020;8:e1457–e14e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572106</ArticleId><ArticleId IdType="pubmed">33091372</ArticleId></ArticleIdList></Reference><Reference><Citation>Visseaux B., Le Hingrat Q., Collin G., Bouzid D., Lebourgeois S., Le Pluart D., et al. Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection. J. Clin. Microbiol. 2020;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383528</ArticleId><ArticleId IdType="pubmed">32341142</ArticleId></ArticleIdList></Reference><Reference><Citation>Boers S.A., Peters C.J.A., Wessels E., Melchers W.J.G., Claas E.C.J. Performance of the QIAstat-Dx gastrointestinal panel for diagnosing infectious gastroenteritis. J. Clin. Microbiol. 2020;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7041566</ArticleId><ArticleId IdType="pubmed">31915286</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebourgeois S., Storto A., Gout B., Le Hingrat Q., Ardila Tjader G., Cerdan M.D.C., et al. Performance evaluation of the QIAstat-Dx(R) respiratory SARS-CoV-2 panel. Int. Infect. Diseases: IJID: Official Publication of the Int. Soc. Infect. Diseases. 2021;107:179–181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064816</ArticleId><ArticleId IdType="pubmed">33901651</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bars H., Madany N., Lamoureux C., Beauruelle C., Vallet S., Payan C., et al. Evaluation of the performance characteristics of a new POC multiplex PCR assay for the diagnosis of viral and bacterial neuromeningeal infections. Diagnostics (Basel) 2023;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10047878</ArticleId><ArticleId IdType="pubmed">36980418</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadakis G., Tran T., Druce J., Lim C.K., Williamson D.A., Jackson K. Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses. J Clin. Virol. 2023;161</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10020139</ArticleId><ArticleId IdType="pubmed">36963141</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado-Barrueco A., Sanz-Gonzalez C., Gutierrez-Arroyo A., Grandioso-Vas D., Roces-Alvarez P., Sendagorta-Cudos E., et al. Sexually transmitted infections and clinical features in monkeypox (mpox) patients in Madrid, Spain. Travel Med. Infect. Dis. 2023;52</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9846951</ArticleId><ArticleId IdType="pubmed">36669636</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouzid D., Lucet J.C., Duval X., Houhou-Fidouh N., Casalino E., Visseaux B., et al. Multiplex PCR implementation as point-of-care testing in a French emergency department. J. Hosp. Infect. 2020;105:337–338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134416</ArticleId><ArticleId IdType="pubmed">32032615</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal S.G., Tremblay E.E., Toffel S., Velez L., Rand K.H. A gastrointestinal PCR panel improves clinical management and lowers health care costs. J. Clin. Microbiol. 2018;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5744222</ArticleId><ArticleId IdType="pubmed">29093106</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>